These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11159560)

  • 1. Nevirapine should not be prescribed for needlestick injuries.
    Gottlieb S
    BMJ; 2001 Jan; 322(7279):126. PubMed ID: 11159560
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
    Sha BE; Proia LA; Kessler HA
    JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
    Johnson S; Baraboutis JG
    JAMA; 2000 Dec; 284(21):2722-3. PubMed ID: 11105175
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatotoxicity with antiretroviral therapy. The liver is affected as well].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():14-5. PubMed ID: 12043064
    [No Abstract]   [Full Text] [Related]  

  • 5. Needlestick injury. Anti-HIV drug branded 'lethal'.
    Nurs Times; 2001 Jan 18-24; 97(3):5. PubMed ID: 11954156
    [No Abstract]   [Full Text] [Related]  

  • 6. Nevirapine and postexposure prophylaxis for human immunodeficiency virus.
    Haehl M
    JAMA; 2001 Feb; 285(7):883. PubMed ID: 11180728
    [No Abstract]   [Full Text] [Related]  

  • 7. [U.S. warns on some use of anti-AIDS drug].
    Hayashi T
    Yakugaku Zasshi; 2001 Sep; 121(9):679-82. PubMed ID: 11558152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines in accidental injury of a caretaker in contact with a blood product in the framework of HIV infection].
    Daher M; Mokhbat JE
    J Med Liban; 1998; 46(3):156-9. PubMed ID: 10095848
    [No Abstract]   [Full Text] [Related]  

  • 9. Nevirapine-associated hepatotoxicity in virologically suppressed patients--role of gender and CD4+ cell counts.
    Mallolas J
    AIDS Rev; 2006; 8(4):238-9. PubMed ID: 17219738
    [No Abstract]   [Full Text] [Related]  

  • 10. From the Centers for Disease Control and Prevention. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
    JAMA; 2001 Jan 24-31; 285(4):402-3. PubMed ID: 11263401
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatotoxicity associated with nevirapine use.
    Baylor MS; Johann-Liang R
    J Acquir Immune Defic Syndr; 2004 Apr; 35(5):538-9. PubMed ID: 15021321
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV.
    Rey D; L'Héritier A; Lang JM
    Clin Infect Dis; 2002 Feb; 34(3):418-9. PubMed ID: 11774091
    [No Abstract]   [Full Text] [Related]  

  • 13. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jan; 49(51-52):1153-6. PubMed ID: 11198946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of nevirapine.
    Goldschmidt RH; Bangsberg D
    Lancet; 2001 Aug; 358(9280):505-6; author reply 506. PubMed ID: 11515513
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse effects of nevirapine.
    Das S; Allan PS; Wade AA
    Lancet; 2001 Aug; 358(9280):506; author reply 506. PubMed ID: 11515514
    [No Abstract]   [Full Text] [Related]  

  • 16. PHS updates guidelines on chemoprophylaxis after occupational HIV exposure.
    Am J Health Syst Pharm; 1996 Aug; 53(15):1764-6. PubMed ID: 8842306
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver transplantation for fulminant hepatitis related to nevirapine therapy.
    Buyse S; Vibert E; Sebagh M; Antonini T; Ichai P; Castaing D; Samuel D; Duclos-Vallée JC
    Liver Transpl; 2006 Dec; 12(12):1880-2. PubMed ID: 17133571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most common prescribing error in postexposure prophylaxis of HIV/AIDS.
    Mahajan A; Sharma H; Bhagat A; Tandon VR; Sharma R; Sharma S
    J Assoc Physicians India; 2007 Mar; 55():246-7. PubMed ID: 17598343
    [No Abstract]   [Full Text] [Related]  

  • 19. [Delayed virus suppression has its price. Heart and liver are no longer secondary theaters].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():12-4. PubMed ID: 12043063
    [No Abstract]   [Full Text] [Related]  

  • 20. Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.
    Tebruegge M; Ritz N; Connell T; Curtis N
    Pediatr Infect Dis J; 2008 Nov; 27(11):1041-2. PubMed ID: 18833024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.